Suven Life Sciences

BSE : 530239 | NSE : SUVEN

Industry : Pharma Research | ISIN : INE495B01038 | FreeFloat : 40.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)-209.87
Net Worth (NW)79.82
Intrinsic Worth (IW)-130.05
Market Cap (MC)1,021.31
Economic Value Added-18.40
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-161.37%
IC Gross Margin (EBITDA/IC)49.99%
IC Net Margin (NPT/IC)50.53%
Knowledge Turnover (Sales/IC)-0.06
Market to Intrinsic Value (MC/IW)-7.85

As OfIntrinsic ValueMarket Price
30 Jun 2022Rs. -8.95Rs. 70.25
8 Aug 2022 ---- Rs. 71.50
-0.15     -0.21%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 71.09ReduceSell
KB > 50% : No50 DMA : Rs. 72.29
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Sep-19
C
1.39
3.77
-21.08
-22.50
-20.22
-19.81
-19.81
Dec-19
C
2.77
8.63
-27.66
-28.52
-22.77
-22.81
-22.81
Mar-20
C
8.66
11.66
-22.07
-23.13
-23.36
-25.56
-25.75
Jun-20
C
1.43
3.96
-11.67
-12.73
-12.96
-10.49
-10.49
Sep-20
C
8.98
11.26
-15.32
-16.39
-16.65
-15.66
-15.66
Dec-20
C
1.51
3.14
-24.98
-26.12
-26.30
-24.39
-24.39
Mar-21
C
1.56
2.88
-20.26
-21.32
-21.57
-21.61
-21.61
Jun-21
C
2.01
6.56
-38.02
-39.06
-39.21
-39.21
-39.21
Sep-21
C
1.18
1.69
-27.11
-28.15
-28.30
-28.30
-28.30
Dec-21
C
4.43
4.57
-32.34
-33.56
-33.69
-33.69
-33.69
Mar-22
C
4.22
4.34
-19.60
-20.70
-20.80
-20.80
-20.80
Jun-22
C
3.54
3.98
-20.64
-22.22
-22.33
-16.33
-16.33
* C - Consolidated, S - Standalone